Literature DB >> 14624076

Late complications in childhood central nervous system tumour survivors.

Neil E Anderson1.   

Abstract

PURPOSE OF REVIEW: As the treatment of childhood brain tumours has improved, long-term survival has become more common. Cognitive, physical and psychological complications of the tumour and its treatment have been recognized more frequently in long-term survivors. This review highlights new studies on the cognitive and endocrine complications in survivors. Less-common late effects of treatment are also discussed. RECENT
FINDINGS: Cognitive abnormalities and endocrine dysfunction are the most common complications in long-term survivors. Radiotherapy is the main cause of cognitive dysfunction, but intrathecal methotrexate and surgery are contributory factors. New studies have provided information on the frequency of endocrine complications and risk factors for the development of endocrine disorders. Endocrine complications are uncommon when the tumour has been treated with surgery alone. The risk of developing endocrine dysfunction is increased by radiotherapy, and some studies suggest that chemotherapy has an additional deleterious effect. Primary hypothyroidism may be caused by scattered irradiation from spinal and cranial radiotherapy. Direct involvement of the hypothalamus by the tumour, and hypothalamic damage secondary to surgery or radiotherapy, may cause obesity. Hypothalamic tumours also may be associated with hypersomnolence and other features consistent with narcolepsy. The pathogenesis of hypersomnolence in these patients has not been resolved. Long-term childhood brain-tumour survivors are 40 times more likely to develop a stroke than sibling controls. Superficial siderosis of the central nervous system can develop many years after curative treatment of a cerebellar tumour, but effective treatment for this disorder is not yet available.
SUMMARY: An attempt to understand the factors that contribute to the long-term morbidity of childhood brain tumours can lead to changes in treatment that improve the quality of life in survivors. Prevention, early recognition and treatment of these complications are attainable goals.

Entities:  

Mesh:

Year:  2003        PMID: 14624076     DOI: 10.1097/01.wco.0000102623.38669.e5

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  20 in total

1.  Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland.

Authors:  Pinki K Prasad; Lisa B Signorello; Debra L Friedman; John D Boice; Eero Pukkala
Journal:  Pediatr Blood Cancer       Date:  2011-09-09       Impact factor: 3.167

2.  Executive functions and social skills in survivors of pediatric brain tumor.

Authors:  Kelly R Wolfe; Karin S Walsh; Nina C Reynolds; Frances Mitchell; Alyssa T Reddy; Iris Paltin; Avi Madan-Swain
Journal:  Child Neuropsychol       Date:  2012-03-15       Impact factor: 2.500

Review 3.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

4.  Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation.

Authors:  Adam T Schmidt; Rebecca B Martin; Arzu Ozturk; Wendy R Kates; Moody D Wharam; E Mark Mahone; Alena Horska
Journal:  Neurocase       Date:  2010-02       Impact factor: 0.881

5.  Incidence of vasculopathy in children with hypothalamic/chiasmatic gliomas treated with brachytherapy.

Authors:  U Tacke; D Karger; J Spreer; A Berlis; G Nikkhah; R Korinthenberg
Journal:  Childs Nerv Syst       Date:  2011-03-17       Impact factor: 1.475

Review 6.  Executive dysfunction in pediatric posterior fossa tumor survivors: a systematic literature review of neurocognitive deficits and interventions.

Authors:  Kelly R Wolfe; Avi Madan-Swain; Rajesh K Kana
Journal:  Dev Neuropsychol       Date:  2012       Impact factor: 2.253

Review 7.  Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.

Authors:  Glenn Bauman; Barbara Fisher; Elizabeth Cairney; Adriana Ranger; A Rashid Dar; Jill Ross; Larry Stitt; David MacDonald
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

8.  Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.

Authors:  Emilie A Steffen-Smith; Pamela L Wolters; Paul S Albert; Eva H Baker; Kim C Shimoda; Alan S Barnett; Katherine E Warren
Journal:  Childs Nerv Syst       Date:  2008-02-22       Impact factor: 1.475

9.  An fMRI investigation of working memory and its relationship with cardiorespiratory fitness in pediatric posterior fossa tumor survivors who received cranial radiation therapy.

Authors:  Kelly R Wolfe; Avi Madan-Swain; Gary R Hunter; Alyssa T Reddy; James Baños; Rajesh K Kana
Journal:  Pediatr Blood Cancer       Date:  2012-10-05       Impact factor: 3.167

10.  Diffusion Tensor Imaging and Neurobehavioral Outcome in Children With Brain Tumors Treated With Chemotherapy.

Authors:  Mary Baron Nelson; Peggy Compton; Paul M Macey; Sunita K Patel; Eufemia Jacob; Sharon O'Neil; Jennifer Ogren; Jonathan L Finlay; Ronald M Harper
Journal:  J Pediatr Oncol Nurs       Date:  2015-07-27       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.